Morphine delivery platform could diminish abuse potential

Researchers at Rutgers University have developed a delivery platform for the extended delivery of morphine for pain management that greatly diminishes the chances of abuse. Using the platform PolyMorphine, the scientists extended the duration of the opioid effect from about four hours to three days, gradually releasing the drug over time instead of offering a quick rush of pain relief, according to the animal study published in the Journal of Controlled Release. Report

Suggested Articles

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

It’s not exactly going to be smooth sailing for Allergan’s multidose bottle version of dry-eye med Restasis. As it finally gets the green light from the FDA, a…

Counting on a novel nasal-spray device to set it apart from its rivals, drug delivery specialist OptiNose is preparing to file its new chronic rhinosinusitis…